SCM
ZYME icon

Silverarc Capital Management’s Zymeworks ZYME Stock Holding History

Silverarc Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-208,330
Closed -$1.1M – 93
2022
Q2 		$1.1M Buy
+208,330
New +$1.26M 0.34% 53
2021
Q1 		– Sell
-30,834
Closed -$1.46M – 104
2020
Q4 		$1.46M Buy
+30,834
New +$1.43M 0.85% 40

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Silverarc Capital Management's ZYME Position: Q3 2022 in Review

Silverarc Capital Management sold out of Zymeworks (ZYME) in Q3 2022, closing a stake of 208,330 shares — an estimated $1.1M sold.

Silverarc Capital Management first reported a position in ZYME in Q4 2020 and held it in 2 quarters. The position peaked at $1.46M in Q4 2020. 91 funds tracked by Wall St. Rank hold ZYME as of Q3 2022.

  • Silverarc Capital Management reported no remaining Zymeworks position as of Q3 2022 after selling out during the quarter.
  • Silverarc Capital Management sold 208,330 Zymeworks shares in Q3 2022, an estimated $1.1M.
  • Silverarc Capital Management first reported a position in Zymeworks in Q4 2020 and held it in 2 quarters.
  • Silverarc Capital Management's Zymeworks position peaked at $1.46M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Zymeworks as of Q3 2022.

Based on Silverarc Capital Management's 13F filing for Q3 2022, filed 28 Oct 2022.